semaglutide and prostate cancer Potential preventive properties of GLP-1 receptor agonists against cancer: a nationwide cohort study | Diabetologia JAMA - Prostate cancer is

The Bottom Line The shifting regulatory picture is potentially good news for patients who can benefit from carefully managed peptide therapy, depending on what the PCAC review concludes in July

Gargling with warm salt water can help reduce swelling and discomfort in the throat

GLP-1 receptor agonists were originally developed as treatments for type 2 diabetes

Telemedicine consultations support weekly check-ins during your first month, allowing real-time assessment of appetite suppression and side-effect management

A 2013 rat medial collateral ligament study also investigated full-length thymosin beta-4 and reported histological and mechanical differences

Collectively, these trends signal an increasingly integrated global response, positioning GLP-1 therapies as core components of metabolic health through the coming decade